Publication |
PUBMEDID |
Hadley J.A., Nenert R., Kraguljac N.V., Bolding M.S., White D.M., Skidmore F.M., Visscher K.M., Lahti A.C. Ventral Tegmental Area/Midbrain Functional Connectivity and Response to Antipsychotic Medication in Schizophrenia. Neuropsychopharmacology, Oct. 29, 2013 |
24165885 |
Kraguljac, N.V., White, D.M., Reid, M.A., Lahti, A.C. Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia. JAMA Psychiatry, Oct. 9, 2013 |
24108440 |
Reid M.A., Kraguljac N.V., Avsar K.B., White D.M., den Hollander J.A., Lahti A.C. Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia. Schizophrenia Research. 2013 Jul;147(2-3):348-54 |
23706412 |
Kraguljac N.V., Srivastava A., Lahti A.C. Memory Deficits in Schizophrenia: A Selective Review of Functional Magnetic Resonance Imaging (fMRI) Studies. Behavioral Sciences. 2013; 3(3):330-347 |
|
Kraguljac N.V., Reid M.A., White D.M., den Hollander J., Lahti A.C. Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia. Neuropsychopharmacology. 2012 Nov;37(12):2635-42 |
22805603 |
Kraguljac, N.V., Reid, M.A., White, D.M., Jones, R., den Hollander, J.A., Lowman, D.K., and Lahti, A.C. Neurometabolites in Schizophrenia and Bipolar - A Systematic Review and Metaanalysis. Psychiatry Research: Neuroimaging, 203(2-3): 111-25. 2012 |
22981426 |
Hutcheson, N.L., Reid, M.A., White, D.M., Kraguljac, N.V., Avasar, K.B., Bolding, M.S., Knowlton, R.C., den Hollander, J.A., and Lahti, A.C. Multimodal Analysis of the Hippocampus in Schizophrenia using Proton Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging. Schizophrenia Research, 140(1-3): 136-42. |
22831772 |
Kraguljac N.V., Montori V.M., Pavuluri M., Chai H.S., Wilson B.S., Unal S.S. Efficacy of omega-3 fatty acids in mood disorders - a systematic review and metaanalysis. Psychopharmacol Bull. 2009;42(3):39-54 |
19752840 |
|